We are live on ! Find out more
FLNA icon

Filana Therapeutics

61 hedge funds and large institutions have $67.2M invested in Filana Therapeutics in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 30 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

58% more call options, than puts

Call options by funds: $136K | Put options by funds: $86K

9% less capital inflows, than outflows

Capital inflows: $5.2M | Capital outflows: $5.74M

12% less funds holding

Funds holding: 69 → 61 (-8)

47% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 15

63% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 30

Holders
61
Holders Change
-8
Holders Change %
-11.59%
% of All Funds
1.97%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
8
Increased
11
Reduced
30
Closed
15
Calls
$136​K
Puts
$86​K
Net Calls
+$50​K
Net Calls Change
-⁠$2.24​M

FLNA Hedge Fund Activity: Q3 2013 in Review

61 of the 3,095 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2013, worth a combined $67.2M — up 21% from $55.4M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of FLNA and 8 opened new positions — a net loss of 7 holders — while 30 trimmed existing stakes and 11 added.

The largest buyer was Great Point Partners, adding an estimated $1.47M. The largest seller was Wellington Management Group, exiting entirely with an estimated $1.44M sold.

  • 61 institutional investors held Filana Therapeutics (FLNA) as of Q3 2013, down from 69 in Q2 2013.
  • Funds reported $67.2M of Filana Therapeutics stock for Q3 2013, up 21% quarter-over-quarter.
  • 8 funds opened new Filana Therapeutics positions in Q3 2013 and 15 closed out, a net change of -7 holders.
  • The largest Filana Therapeutics buyer in Q3 2013 was Great Point Partners, an estimated $1.47M added.
  • The largest Filana Therapeutics seller in Q3 2013 was Wellington Management Group, an estimated $1.44M sold.

Based on aggregated 13F filings for Q3 2013.